Business Description
Bristol-Myers Squibb Co
NAICS : 325412
SIC : 2834
ISIN : US1101222073
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.17 | |||||
Equity-to-Asset | 0.17 | |||||
Debt-to-Equity | 3.48 | |||||
Debt-to-EBITDA | 10.79 | |||||
Interest Coverage | 5.58 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.23 | |||||
Beneish M-Score | -2.92 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.8 | |||||
3-Year EBITDA Growth Rate | 62.2 | |||||
3-Year EPS without NRI Growth Rate | 5.3 | |||||
3-Year FCF Growth Rate | 1.1 | |||||
3-Year Book Growth Rate | -5.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | -4.45 | |||||
Future 3-5Y Total Revenue Growth Rate | -1 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 7.92 | |||||
9-Day RSI | 17.51 | |||||
14-Day RSI | 25.14 | |||||
6-1 Month Momentum % | -8.28 | |||||
12-1 Month Momentum % | -25.04 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.11 | |||||
Quick Ratio | 0.99 | |||||
Cash Ratio | 0.37 | |||||
Days Inventory | 86.16 | |||||
Days Sales Outstanding | 67.49 | |||||
Days Payable | 104.78 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.25 | |||||
3-Year Dividend Growth Rate | 7.9 | |||||
Forward Dividend Yield % | 0.25 | |||||
5-Year Yield-on-Cost % | 0.37 | |||||
3-Year Average Share Buyback Ratio | 3.1 | |||||
Shareholder Yield % | 6.74 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 75.71 | |||||
Operating Margin % | 15.98 | |||||
Net Margin % | -13.5 | |||||
ROE % | -22.16 | |||||
ROA % | -6.5 | |||||
ROIC % | 9.31 | |||||
ROC (Joel Greenblatt) % | -57.79 | |||||
ROCE % | -6.27 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 6.45 | |||||
PE Ratio without NRI | 13.13 | |||||
Shiller PE Ratio | 36.17 | |||||
PEG Ratio | 0.54 | |||||
PS Ratio | 2.02 | |||||
PB Ratio | 5.51 | |||||
Price-to-Free-Cash-Flow | 7.35 | |||||
Price-to-Operating-Cash-Flow | 6.7 | |||||
EV-to-EBIT | -30.52 | |||||
EV-to-EBITDA | 26.06 | |||||
EV-to-Revenue | 3.04 | |||||
EV-to-FCF | 11.08 | |||||
Price-to-DCF (Earnings Based) | 0.46 | |||||
Price-to-DCF (FCF Based) | 0.24 | |||||
Earnings Yield (Greenblatt) % | -3.28 | |||||
FCF Yield % | 13.76 | |||||
Forward Rate of Return (Yacktman) % | 27.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BMYMP.PFD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Bristol-Myers Squibb Co Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | 0 | ||
Beta | -0.19 | ||
Volatility % | 19.85 | ||
14-Day RSI | 25.14 | ||
14-Day ATR ($) | 5.487255 | ||
20-Day SMA ($) | 837.2 | ||
12-1 Month Momentum % | -25.04 | ||
52-Week Range ($) | 700 - 1255.01 | ||
Shares Outstanding (Mil) |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bristol-Myers Squibb Co Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bristol-Myers Squibb Co Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Bristol-Myers Squibb Co Frequently Asked Questions
What is Bristol-Myers Squibb Co(BMYMP.PFD)'s stock price today?
When is next earnings date of Bristol-Myers Squibb Co(BMYMP.PFD)?
Does Bristol-Myers Squibb Co(BMYMP.PFD) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |